Transcreener GDP Assay directly measures GDP produced by NRAS (Neuroblastoma Rat Sarcoma Virus Oncogene Homolog). These GDP measurements allow researchers to effectively determine the activity of the NRAS enzyme. The assay provides a powerful tool to screen compound libraries for NRAS modulators to help find new therapies for disease.
The kit comes complete with the detection reagents required to measure activity. NRAS enzyme is not included in the inhibitor screening assay kit. Please contact us for questions related to acquiring the enzyme.
This assay is designed to be used with purified enzyme preparations. Transcreener assays are not validated with cell lysates, blood, serum, or other biological samples.
The Transcreener NRAS Assay determines NRAS enzyme activity by directly measuring the GDP formed by the enzyme using the Transcreener GDP Assay. By detecting GDP output, the assay provides a universal method to assess the activity of any GDP-producing enzyme in real time.
Transcreener NRAS Assay technology uses a simple but highly effective method that consists of an antibody selective to GDP and a far-red fluorescent tracer. GDP produced in the reaction competes with the tracer changing the fluorescent properties and providing fluorescent readout.
The NRAS assay is available with FP, FI, and TR-FRET. It is an easy-t0-use mix-and-read format. Perform your enzyme reaction, add the detection reagents, and measure. The simplicity of the system yields robust results that also make it extremely amiable to HTS.
Run your enzyme reaction, add Transcreener reagents, and read your plates. The NRAS assay is compatible with 96, 384, and 1536-well formats.
EDTA enhances the GDP exchange and GTP hydrolysis of some GTPases. The assay conditions below are chosen to generate the best assay window and ability to study the enzyme. The assay demonstrates linearity when raw data is converted to GDP using a standard curve. Here we use 2 µM GTP. The enzyme buffer includes 20 mM Tris pH 7.5, 75 mM NaCl, 5 mM MgCl2, 0.1 mg/mL BSA, and 1 mM DTT. The Detection mix included 10 μg/mL GDP antibody and 4 nM GDP Alexa 633 tracer. The NRAS enzyme reaction took place for 60, 120, and 180 minutes. The Detection Mix was added with the substrate to start the reaction and incubated at 30°C. Readings were taken with a CLARIOstar plate reader.
Optimal Assay Conditions: 125 nM NRAS for 2 hours with 10 mM EDTA achieves >150 mP assay window and 20% conversion
The assay demonstrates linearity when raw data is converted to GDP using a standard curve. Here we use 2 µM GTP. The enzyme buffer includes 30 mM HEPES (pH 7.5), 150 mM KCl, 20 mM NaCl, 1 mM DTT, 0.01% BSA. The Detection mix included 10 μg/mL GDP antibody and 4 nM GDP Alexa 633 tracer. The NRAS enzyme reaction took place for 2 hours. The Detection Mix was added with the substrate to start the reaction and incubated at 30°C. Readings were taken with a CLARIOstar plate reader.
Optimal Assay Conditions: 125 nM NRAS for 2 hours.
Interested in moving your program forward, but don’t want to bring an assay in-house? Our scientists can help! BellBrook scientists will use their extensive biochemistry and enzymology expertise to work with you and accelerate your NRAS program (right here in Madison, Wisconsin). We can provide modulator potency profiling for NRAS, along with a variety of other GTPase enzymes, related GAPs, GEFs, and other proteins. Get accurate IC50 results fast to understand how your lead molecule interacts with other GTPases.
Please fill out the form below. We will respond quickly to get the conversation moving and learn how we can help. We keep things discrete, confidential, and professional.
| Component | Notes |
|---|---|
| GDP Antibody | Antibody specific to the nucleotide GDP. Yours may vary depending on enzyme and buffer composition. |
| GDP Tracer | When displaced, changes in fluorescence can be read in an FP, FI, or TR-FRET depending on the assay format. |
| GTP and GDP | GTP and GDP are used to create the GTP/GDP standard curve. GTP is used as a phosphate donor to start the reaction. We suggest using a starting GTP concentration of 1 μM for NRAS. |
| Component | Notes |
|---|---|
| NRAS Enzyme | We have successfully used N-Ras Protein: Wild-Type (Human Recombinant) from Cytoskeleton, Inc. #CS-RS02. An NRAS concentration of 125 nM was used for screening and SAR. |
| Enzyme Buffer | 20 mM Tris (pH 7.5), 75 mM NaCl, 5 mM MgCl2, 0.1 mg/mL BSA, 1 mM DTT, and EDTA (20, 10, 5, 2.5, or 1 mM). Enzyme Buffer components may be optimized as required. |
| EDTA | 20, 10, 5, 2.5, or 1 mM EDTA |
| Assay Plates | Assay Plates Can Be Purchased Directly Through BellBrook Labs FP - An entirely black plate with a non-binding surface is required. We suggest Corning 384-well plates Cat. #4514 FI - An entirely black plate with a non-binding surface is required. We suggest Corning 384-well plates Cat. #4514 TR-FRET - An entirely white plate with a non-binding surface is required. We suggest Corning 384-well plates Cat. #4513 |
| Plate Reader | A multi-detection microplate reader configured to measure the output of the GDP tracer is required. |
| Liquid Handling Devices | Use liquid handling devices that can accurately dispense sub-microliter volumes into 384-well plates. |
| Ultrapure Water | Some deionized water systems are contaminated with nucleases that can degrade both nucleotide substrates and products, reducing assay performance. Careful handling and use of ultrapure water eliminates this potential problem. |
NRAS is part of the RAS GTPase family oncogenes, which have high mutation rates among several poor prognosis cancers. In the past, directly targeting RAS oncogenes in drug discovery seemed impossible; however, recent advancements in drugging RAS-target therapies show promise for therapeutic cancer treatments. With NRAS, there is hope for targeting several NRAS mutated malignancies, such as NRAS mutant metastatic melanoma (Boespflug et al, 2017).
The Transcreener GDP NRAS Assay is an excellent tool for researchers examining NRAS for therapeutic treatments.
Find the right resources to help you get to your solution faster.
Please fill out the form below. We will respond quickly to get the conversation moving and learn how we can help. We keep things discrete, confidential, and professional.
BellBrook Labs
1232 Fourier Drive, Suite 115
Madison, Wisconsin 53717 USA
(608) 443-2400
info@bellbrooklabs.com
